Please Wait.....
Report
Ophthalmic Drugs and Devices Market-Forecast till 2030
Market Report I 2022-12-06 I 136 Pages I Market Research Future
Ophthalmic Drugs and Devices Market-Forecast till 2030
Market Overview
From 2022 to 2030, the market for ophthalmic medications and devices is anticipated to grow at a CAGR of 9.20%. Eye diseases are treated with deep cleaning, specialist contact lenses, and other tools. The global market for ophthalmic medications and equipment is being driven by reasons like a growing older population, rising diabetes occurrences, and a growing prevalence of ocular diseases. Additionally, it is anticipated that increasing product launches and development would generate profitable growth prospects.
The first over-the-counter remedy that doctors frequently suggest is artificial tears. Eye diseases are treated with deep cleaning, specialist contact lenses, and other tools. The global market for ophthalmic medications and equipment is being driven by reasons like a growing older population, rising diabetes occurrences, and a growing prevalence of ocular diseases. Additionally, it is anticipated that increasing product launches and development would generate profitable growth prospects.
Segment Overview
Based on the product and therapy, the global market for ophthalmic medications and devices has been segmented. The market is divided into two categories based on product: pharmaceuticals and devices. Pilocarpine, Micropine, Provisc, Diuretics, Vasoconstrictors, Fluocinolone, Bimatoprost, and Others are other subcategories of the drugs category. The market is divided into the following sub-segments based on devices: Sponge Devices and Eye Cleaner, Others, Eye Massagers, Optical Dispenser, Glasses and Contact Lens, and Others. The global market for ophthalmic medications and devices has been divided into categories based on the conditions they treat, including eye infections, allergic conjunctivitis, dry eye syndrome, red eyes, inflammation, and others.
Regional Analysis
Geographically, the worldwide ophthalmic drugs and devices market, has been isolated into North America, Europe, Asia-Pacific, and the Rest of the World.
North America is supposed to lead the worldwide market attributable to the rising predominance of eye sickness and the presence of many market players in the locale, which are driving the ophthalmic drugs and gadget market in North America. The developing geriatric populace in created nations in the district and the rising commonness of persistent eye conditions because of high pressure and undesirable ways of life bringing about diabetic retinopathy are supporting the ophthalmic drugs and devices market in Europe. The rising pace of waterfall sight misfortune issues represented a significant effect on the ophthalmic market, bringing about rising demand for ophthalmic drugs and devices in Europe.
In the Asia-Pacific district, the rising weight of ophthalmic issues and rising purchaser mindfulness are the main considerations energizing the ophthalmic drugs and devices market. Organizations are going into coordinated efforts and key drives to create and market new treatment choices for patients. The remainder of the world represented the least market share in the ophthalmic drugs and devices market. The developing headways in clinical foundation and rising health care coverage inclusion are the central point driving the development of the market in the remainder of the world.
Key Players
The prominent players in the global ophthalmic drugs and devices market are Allergan plc (Ireland), Johnson & Johnson Vision (US), Alcon (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Ocular Therapeutix, Inc. (US), Lomb Incorporated (Canada), Sight Sciences, Inc. (US), Mibo Medical Group (US), BioTissue (US), and NuSight Medical (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 RISING PREVALENCE OF OPHTHALMIC DISORDERS
4.2.2 RISING GERAITRIC POPULATION
4.2.3 GROWING NUMBER OF DIABETES CASES
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS REGARDING EYE DISORDERS
4.3.2 SIDE EFFECTS ASSOCIATED WITH OPHTHALMIC DRUGS
4.4 OPPORTUNITIES
4.4.1 INCREASE PRODUCT DEVELOPMENT AND LAUNCHES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE OPHTHALMIC DRUGS AND DEVICES MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 IMPACT ON MARKET PLAYERS
6 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 DRUGS
6.2.1 PILOCARPINE
6.2.2 MICROPINE
6.2.3 PROVISC
6.2.4 DIURETICS
6.2.5 VASOCONSTRICTORS
6.2.6 FLUOCINOLONE
6.2.7 BIMATOPROST
6.2.8 OTHERS
6.3 DEVICES
6.3.1 GLASSES AND CONTACT LENS
6.3.2 OPTICAL DISPENSER
6.3.3 EYE MASSAGERS
6.3.4 SPONGE DEVICES AND EYE CLEANER
6.3.5 OTHERS
7 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 EYE INFECTIONS
7.3 ALLERGIC CONJUNCTIVITIS
7.4 DRY EYES SYNDROME
7.5 RED EYES
7.6 INFLAMMATION
7.7 OTHERS
8 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 UK
8.3.3 FRANCE
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 AUSTRALIA
8.4.5 SOUTH KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
8.5.1 MIDDLE EAST
8.5.2 AFRICA
8.5.3 LATIN AMERICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPETITIVE BENCHMARKING
9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
9.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
9.5 KEY DEVELOPMENT ANALYSIS
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCH
9.6.2 COLLABORATION
9.6.3 AGREEMENT
9.6.4 ACQUISITION
9.7 MAJOR PLAYERS FINANCIAL MATRIX
9.7.1 SALES (USD MILLION), 2021
9.7.2 R&D (USD MILLION), 2021
10 COMPANY PROFILES
10.1 JOHNSON AND JOHNSON VISION
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 ALLERGAN PLC
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 TEVA PHARMACEUTICAL INDUSTRIES LTD.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL ANALYSIS
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 KEY STRATEGIES
10.4 OCULAR THERAPEUTIX, INC
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 BAUSCH & LOMB INCORPORATED
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 SIGHT SCIENCES, INC.
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL ANALYSIS
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 MIBO MEDICAL GROUP
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIES
10.8 ALCON
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS 0FFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 BIOTISSUE
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIES
10.10 NUSIGHT MEDICAL
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR PILOCARPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR MICROPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR PROVISC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DIURETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR VASOCONSTRICTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR FLUOCINOLONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR BIMATOPROST, BY REGION, 2018-2030 (USD MILLION)
TABLE 14 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR GLASSES AND CONTACT LENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OPTICAL DISPENSER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR EYE MASSAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR SPONGE DEVICES AND EYE CLEANER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR EYE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRY EYES SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 25 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR RED EYES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, FOR OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28 GLOBAL: OPHTHALMIC DRUGS AND DEVICES MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 29 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34 US: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35 US: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36 US: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37 US: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41 CANADA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50 GERMANY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54 UK: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58 FRANCE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62 ITALY: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66 SPAIN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70 REST OF EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 77 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79 JAPAN: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83 CHINA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87 INDIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91 AUSTRALIA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95 SOUTH KOREA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96 REST OF ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97 REST OF ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98 REST OF ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99 REST OF ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100 REST O F THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101 REST OF THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102 REST OF THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103 REST OF THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104 REST OF THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105 MIDDLE EAST: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106 MIDDLE EAST: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107 MIDDLE EAST: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108 MIDDLE EAST: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109 AFRICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110 AFRICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111 AFRICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112 AFRICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113 LATIN AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114 LATIN AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DRUGS, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115 LATIN AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, FOR DEVICES, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116 LATIN AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117 MAJOR PLAYERS IN THE GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
TABLE 118 MOST ACTIVE PLAYERS IN THE GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
TABLE 119 PRODUCT LAUNCH
TABLE 120 COLLABORATION
TABLE 121 AGREEMENT
TABLE 122 ACQUISITION
TABLE 123 JOHNSON AND JOHNSON VISION: PRODUCTS OFFERED
TABLE 124 JOHNSON AND JOHNSON: KEY DEVELOPMENTS
TABLE 125 ALLERGAN PLC: PRODUCTS OFFERED
TABLE 126 ALLERGAN PLC: KEY DEVELOPMENTS
TABLE 127 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 128 OCULAR THERAPEUTIX, INC.: PRODUCTS OFFERED
TABLE 129 OCULAR THERAPEUTIX, INC.: KEY DEVELOPMENTS
TABLE 130 BAUSCH & LOMB INCORPORATED: PRODUCTS OFFERED
TABLE 131 BAUSCH & LOMB INCORPORATED: KEY DEVELOPMENTS
TABLE 132 SIGHT SCIENCES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 133 SIGHT SCIENCES, INC.: KEY DEVELOPMENTS
TABLE 134 MIBO MEDICAL GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 135 ALCON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 136 ALCON: KEY DEVELOPMENTS
TABLE 137 BIOTISSUE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
TABLE 138 NUSIGHT MEDICAL: PRODUCTS/SERVICES OFFERED
TABLE 139 NUSIGHT MEDICAL: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
FIGURE 5 DRIVERS: IMPACT ANALYSIS
FIGURE 6 RESTRAINT: IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
FIGURE 9 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY PRODUCT, 2021 & 2030 (USD MILLION)
FIGURE 10 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY PRODUCT, 2021
FIGURE 11 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET, BY TREATMENT, 2021 & 2030 (USD MILLION)
FIGURE 12 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY TREATMENT, 2021
FIGURE 13 GLOBAL: OPHTHALMIC DRUGS AND DEVICES MARKET, BY REGION 2021 & 2030 (USD MILLION)
FIGURE 14 GLOBAL: OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY REGION 2021
FIGURE 15 NORTH AMERICA: OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 16 EUROPE: OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 17 ASIA-PACIFIC: OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 18 REST OF THE WORLD: OPHTHALMIC DRUGS AND DEVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 20 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET
FIGURE 21 GLOBAL OPHTHALMIC DRUGS AND DEVICES MARKET: COMPETITIVE LANDSCAPE
FIGURE 22 SALES, 2021
FIGURE 23 R&D, 2021
FIGURE 24 JOHNSON AND JOHNSON VISION: SWOT ANALYSIS
FIGURE 25 ALLERGAN PLC: SWOT ANALYSIS
FIGURE 26 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 28 OCULAR THERAPEUTIX, INC.: FINANCIAL OVERVIEW
FIGURE 29 OCULAR THERAPEUTIX, INC.: SWOT ANALYSIS
FIGURE 30 BAUSCH & LOMB INCORPORATED: SWOT ANALYSIS
FIGURE 31 SIGHT SCIENCES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ALCON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 ALCON: SWOT ANALYSIS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security